To hear about similar clinical trials, please enter your email below

Trial Title: Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions

NCT ID: NCT02238990

Condition: Evaluation of New Tissue Biomarkers for Cervical Cancer

Conditions: Official terms:
Uterine Cervical Neoplasms

Study type: Observational

Overall status: Active, not recruiting

Study design:

Time perspective: Prospective

Summary: The following trial is a multicenter and prospective research trial of the colposcopy unit of luebeck university and the national research center in Borstel, Germany. The study is to identify and evaluate new biomarkers in human papilloma virus (HPV) associated malignancies and its preinvasive lesions of the cervix uteri. Fresh tissue samples being removed during conizations and/or hysterectomies are to be fixed in HOPE's solution and analyzed according to their transcriptomes and methylosome. The hereby found candidates are to be validated using immunohistochemistry and RT [real-time] -PCR [polymerase chain reaction]. The project is meant to be followed by continuous studies developing a new test describing the malignant potential of HPV associated genital lesions.

Criteria for eligibility:

Study pop:
The population is to be recruted from A. patients suffering from cervical cancer B. patients suffering from preinvasive cervical lesions

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Positive informed consent - Patients with suspected preinvasive genital lesion - Patients with confirmed genital lesion (both preinvasive and invasive) - Contact via dept. of obs/gyn of luebeck university - Complete set of data Exclusion Criteria: - Incomplete set of data - Negative informed consent

Gender: Female

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Luebeck University, Department for obstetrics and gynecology

Address:
City: Luebeck
Zip: D-23538
Country: Germany

Start date: September 2014

Completion date: December 1, 2030

Lead sponsor:
Agency: University of Luebeck
Agency class: Other

Source: University of Luebeck

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT02238990

Login to your account

Did you forget your password?